These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 465366)

  • 1. Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases.
    Benbassat J; Penchas S; Ligumski M
    Br J Haematol; 1979 Jun; 42(2):207-14. PubMed ID: 465366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Early' splenectomy and survival in agnogenic myeloid metaplasia. An analysis of 338 cases published since 1940.
    Benbassat J; Penchas S
    Acta Haematol; 1981; 65(3):189-92. PubMed ID: 6785973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with splenectomy in auto-immune thrombocytopenia and agnogenic myeloid metaplasia.
    Heaton A; Jacobs P; Dent DM; Louw JH
    S Afr Med J; 1976 Sep; 50(39):1506-12. PubMed ID: 988641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex and splenectomy in agnogenic myeloid metaplasia.
    Benbassat J; Penchas S
    Acta Haematol; 1980; 64(2):114-6. PubMed ID: 6776767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia.
    Brenner B; Tavori S; Tatarsky I
    Haemostasis; 1987; 17(3):141-6. PubMed ID: 3609915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy in myeloid metaplasia.
    Silverstein MN; ReMine WH
    Blood; 1979 Mar; 53(3):515-8. PubMed ID: 760865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasia.
    DiBella NJ; Silverstein MN; Hoagland HC
    Arch Intern Med; 1977 Mar; 137(3):380-1. PubMed ID: 843155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
    Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
    Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
    Varki A; Lottenberg R; Griffith R; Reinhard E
    Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia.
    Benbassat J; Gilon D; Penchas S
    Am J Hematol; 1990 Feb; 33(2):128-35. PubMed ID: 1689100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy in agnogenic myeloid metaplasia: factors of possible prognostic significance.
    Penchas S; Steinwel A; Sukenik S; Benbassat J
    Postgrad Med J; 1982 Apr; 58(678):212-5. PubMed ID: 7111100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.
    Barosi G; Ambrosetti A; Centra A; Falcone A; Finelli C; Foa P; Grossi A; Guarnone R; Rupoli S; Luciano L; Petti MC; Pogliani E; Russo D; Ruggeri M; Quaglini S
    Blood; 1998 May; 91(10):3630-6. PubMed ID: 9572998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.
    Akpek G; McAneny D; Weintraub L
    J Surg Oncol; 2001 May; 77(1):42-8. PubMed ID: 11344482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy for myelofibrosis.
    Järvinen H; Kivilaakso E; Ikkala E; Vuopio P; Hästbacka J
    Ann Clin Res; 1982 Apr; 14(2):66-71. PubMed ID: 7149614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Splenectomy in idiopathic thrombopenic purpura and in myelofibrosis. A retrospective study of platelet increase, hemorrhagic complications and mortality].
    Hellström P; Ogier C; Askergren J; Sundblad R; Reizenstein P
    Minerva Chir; 1981 Sep; 36(17):1065-8. PubMed ID: 7197336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
    Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
    Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agnogenic myeloid metaplasia: role of splenectomy.
    Marks C; Ahmadi M
    Postgrad Med J; 1969 Apr; 45(522):261-5. PubMed ID: 5821186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
    Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
    Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.